SUNESIS PHARMACEUTICALS INC Stock Agreements
14 Contracts & Agreements
- 2022 Employee Stock Purchase Plan (Filed With SEC on June 8, 2022)
- Description of Capital Stock (Filed With SEC on February 24, 2021)
- Description of Capital Stock (Filed With SEC on May 7, 2020)
- Form of Specimen Series F Preferred Stock Certificate (Filed With SEC on July 12, 2019)
- Form of Specimen Series E Preferred Stock Certificate (Filed With SEC on January 22, 2019)
- Common Stock Purchase Agreement, dated as of June 25, 2018, by and between Sunesis Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (Filed With SEC on June 25, 2018)
- Form of Specimen Series D Preferred Stock Certificate (Filed With SEC on October 26, 2017)
- SUNESIS PHARMACEUTICALS, INC. $20,000,000 of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on August 11, 2011)
- SUNESIS PHARMACEUTICALS, INC. $15,000,000 OfCommon Stock (par value $0.0001 per share) (Filed With SEC on January 21, 2010)
- SUNESIS PHARMACEUTICALS, INC. EMPLOYEE STOCK PURCHASE PLAN (Amended and Restated on September 13, 2006) (Filed With SEC on November 9, 2006)
- SUNESIS PHARMACEUTICALS, INC. EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on September 27, 2005)
- Shares SUNESIS PHARMACEUTICALS, INC. Common Stock $0.0001 Par Value (Filed With SEC on September 27, 2005)
- SUNESIS PHARMACEUTICALS, INC. 2001 STOCK PLAN (Filed With SEC on December 23, 2004)
- SUNESIS PHARMACEUTICALSINCORPORATED 1998 STOCK PLAN (amended as of October 4, 2001) (Filed With SEC on December 23, 2004)
